Matches in Nanopublications for { ?s ?p "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800613.RASwF7bhEyFpWBzqNNfI7p96oqLKPEVALsDxYh9-Wsb4I130_provenance.
- NP800614.RAT7GCbrF8XHTJwttF9x5tD5YeUOp6fvJ3U0tYw45nr20130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800614.RAT7GCbrF8XHTJwttF9x5tD5YeUOp6fvJ3U0tYw45nr20130_provenance.
- NP800615.RAfMXo1ADUWtRSmyMTtQrvJmn_tvRFP5nH3ZOiiZ9CYxA130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800615.RAfMXo1ADUWtRSmyMTtQrvJmn_tvRFP5nH3ZOiiZ9CYxA130_provenance.
- NP718043.RAAhpi1PGth8Js3dMDCpV8iF4Hx1bKM5sh4oKqs4chexk130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718043.RAAhpi1PGth8Js3dMDCpV8iF4Hx1bKM5sh4oKqs4chexk130_provenance.
- NP800610.RAkw6taWEtIThs3A_zy4dwy1S-TfQEVOsXqgv1MZB2kPs130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800610.RAkw6taWEtIThs3A_zy4dwy1S-TfQEVOsXqgv1MZB2kPs130_provenance.
- NP717439.RAKzBkpWmeRuhHfZ6lMfcDZuYHQ-fQ5BPqCZGIyigKy9I130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717439.RAKzBkpWmeRuhHfZ6lMfcDZuYHQ-fQ5BPqCZGIyigKy9I130_provenance.
- NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_assertion description "[The effects of prolactin (PRL) during the pathogenesis of breast cancer are mediated in part though Stat5 activity enhanced by its interaction with its transcriptional inducer, the prolyl isomerase cyclophilin B (CypB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717776.RAHJgT8C9_kvuAv1b0MtOix7KVGmOb5emI18hyI1wQKss130_provenance.